6 results
nsclc durvalumab hematology igg igm ipilimumab melanoma multiplemyeloma nivolumab nonigm osimertinib pacific prbc thresholds transfusion trials visualabstract
Cumulative Incidence of Progression of MGUS, with Death Accounted for as a Competing Risk #EBM #Honc
Cumulative Incidence of Progression ... of MGUS, with Death ... Competing Risk #EBM ... #Honc #MGUS #Progression ... #IgG #MGUS #NEJM
IgM and Non-IgM - Risk and Type of Progression #EBM #Honc #MGUS #Progression #IgM #NonIgM #MultipleMyeloma
Risk and Type of Progression ... #EBM #Honc #MGUS ... #Progression #IgM ... MultipleMyeloma #NEJM
Progression-free Survival #EBM #Honc #Osimertinib #NSCLC #Survival #NEJM
Progression-free ... Survival #EBM ... #Honc #Osimertinib ... #NSCLC #Survival ... #NEJM
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer - Progression-free Survival in the Intention-to-Treat Population.
Lung Cancer - Progression-free ... Survival in the ... #EBM #Honc #PACIFIC ... Durvalumab #NSCLC #NEJM
Major Clinical Trials and Evidence Summary for Transfusion Thresholds in Critical Care TRICC - NEJM 1999 -
Clinical Trials and Evidence ... Care TRICC - NEJM ... - ICU FOCUS - NEJM ... critically ill, septic, surgical ... /vmoitra) #EBM
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma - Recurrence-free Survival in the
Recurrence-free Survival ... Intention-to-Treat Population #EBM ... #Honc #Nivolumab ... Ipilimumab #Melanoma #NEJM
No results found for "Thrombolytics EBM nejm honc evidence mgus progression survival"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #Thrombolytics #EBM #nejm #honc #evidence #mgus #progression #survival